Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor.
## Primary Indications
* Management of anxiety disorders
* Short-term treatment of insomnia
* Preanesthetic medication
* Management of seizures (status epilepticus)
## Adult Dosing
* **Anxiety:** 1-4 mg orally or IM every 6-8 hours as needed. Do not exceed 10 mg in 24 hours.
* **Insomnia:** 1-2 mg orally at bedtime.
* **Preanesthetic Medication:** 2-4 mg IM or IV given 1-2 hours before surgery.
* **Status Epilepticus:** 4 mg IV, may be repeated after 10-15 minutes if necessary. Maximum initial dose is 8 mg.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be individualized based on age, weight, and clinical condition. Consult specific pediatric guidelines or resources.
* **Anxiety:** There is no standard pediatric dose. Use with caution and at the lowest effective dose.
* **Seizures (Status Epilepticus):** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May be repeated after 10-15 minutes if necessary.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is usually required, but monitor for increased sedation.
* **Elderly:** Start with lower doses (e.g., 0.5-1 mg orally twice daily) and titrate cautiously due to increased sensitivity and risk of adverse effects.
## Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, unsteadiness, weakness.
Less Common: Confusion, depression, amnesia, paradoxical excitement, visual disturbances, hypotension, respiratory depression.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death. Use with extreme caution and consider dose reduction of one or both agents.
* **Theophyllines and other xanthines:** May antagonize the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Level of sedation and cognitive function.
* Respiratory rate and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Signs of withdrawal if discontinuation is planned.
* For seizure management, monitor for seizure control and adverse effects.
## Clinical Pearls
* Lorazepam is available in oral, IM, and IV formulations. IM absorption can be variable.
* IV lorazepam should be administered slowly to minimize adverse effects, particularly respiratory depression and hypotension.
* Due to its longer half-life and risk of accumulation, caution is advised with continuous infusions, especially in critically ill patients.
* Abrupt discontinuation can lead to withdrawal symptoms, including rebound anxiety, insomnia, seizures, and tremors. Tapering is recommended.
* Avoid concomitant use with alcohol or other CNS depressants.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the current prescribing information and relevant clinical guidelines for complete and up-to-date information before making any treatment decisions. Dosing may vary based on individual patient factors and local protocols.
